David P Meeker

President and CEO

David P Meeker (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Rhythm Pharmaceuticals, Inc. (RYTM). The largest single filing was $5.1M of RYTM (50,000 sh across 5 lots, as filed), executed Sep 14.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 1 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$5.1M

shares × price, as filed

Last traded

Sep 14

Filed Sep 14

Median ADV $88.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $8.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 1 filing

Sector per market data · by filing · past 12 months

Most traded names

RYTM Rhythm Pharmaceuticals, Inc. RYTM · 0 buys · 4 sells 4 filings

Recent filings

RYTMSALE Rhythm Pharmaceuticals, Inc. View filing → $5.1M
50,000 sh across 5 lots
Exec Sep 14
Filed Sep 14 · 7:37 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. View filing → $2.8M
43,346 sh × $65.04
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. View filing → $566K
9,896 sh × $57.22
Exec Feb 19 2025
Filed Feb 19 2025 · 5:30 PM ET RYTMSALE Rhythm Pharmaceuticals, Inc. View filing → $254K
4,278 sh × $59.43
Exec Feb 4 2025
Filed Feb 4 2025 · 5:30 PM ET